Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prebiotic Treatment in People With Schizophrenia
NCT03617783Phase 4Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Jul 2019
- Primary completion
- Apr 2022
- Modality
- Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oligofructose-enriched inulin in schizophrenia, schizoaffective disorder, sponsored by University of Maryland, Baltimore. Started Jul 2019; status: completed.
02
Drugs
oligofructose-enriched inulin
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT03617783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03617783.